(Q43537472)

24 November 2017

title

Cisplatin affects the conformation of apo form, not holo form, of BRCA1 RING finger domain and confers thermal stability (English)

1 reference

24 November 2017

Cisplatin Affects the Conformation of Apo Form, not Holo Form, of BRCA1 RING Finger Domain and Confers Thermal Stability (English)

1 reference

https://api.crossref.org/works/10.1002/CBDV.200900308

21 June 2024

1 reference

Apichart Atipairin

1

1 reference

24 November 2017

Bhutorn Canyuk

2

1 reference

24 November 2017

Adisorn Ratanaphan

3

1 reference

24 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20730959

21 June 2024

publication date

1 August 2010

1 reference

full work available at URL

24 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcbdv.200900308

1 reference

https://api.crossref.org/works/10.1002/CBDV.200900308

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbdv.200900308

21 June 2024

1 reference

https://api.crossref.org/works/10.1002/CBDV.200900308

Chemistry and Biodiversity

21 June 2024

published in

1 reference

24 November 2017

volume

7

1 reference

24 November 2017

issue

8

1 reference

24 November 2017

page(s)

1949-1967

1 reference

Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Cellular processing of platinum anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Mechanism of transcriptional stalling at cisplatin-damaged DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Cisplatin-damaged BRCA1 exhibits altered thermostability and transcriptional transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Molecular mechanisms involved in cisplatin cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Interaction of cisplatin with human serum albumin. Drug binding mode and protein secondary structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

A mass spectrometric and molecular modelling study of cisplatin binding to transferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Cisplatin binding sites on human albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Determination of drug binding sites to proteins by electrospray ionisation mass spectrometry: the interaction of cisplatin with transferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

The HIV-1 nucleocapsid zinc finger protein as a target of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Targeting retroviral Zn finger-DNA interactions: a small-molecule approach using the electrophilic nature of trans-platinum-nucleobase compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Zinc finger proteins as templates for metal ion exchange: Substitution effects on the C-finger of HIV nucleocapsid NCp7 using M(chelate) species (M=Pt, Pd, Au).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

BRCA1 gene in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Structure of a BRCA1-BARD1 heterodimeric RING-RING complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Targeting the DNA repair defect of BRCA tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

DNA repair pathways as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

DNA repair proteins as molecular targets for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Brca1 controls homology-directed DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Roles of BRCA1 in DNA damage repair: a link between development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Genetic steps of mammalian homologous repair with distinct mutagenic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Platinum-based chemotherapy in triple-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Targeting DNA repair as a promising approach in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

BRCA-FA pathway as a target for anti-tumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Targeted therapies in breast cancer: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Therapeutic options for triple-negative breast cancers with defective homologous recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Platinum sensitivity in a BRCA1 mutation carrier with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Triple-negative breast cancer: novel therapies and new directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

BRCA1 RING domain cancer-predisposing mutations. Structural consequences and effects on protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

The ubiquitin E3 ligase activity of BRCA1 and its biological functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Cisplatin differently affects amino terminal and carboxyl terminal domains of HSP90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Improved survival in women with BRCA-associated ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Metal-dependent folding of a single zinc finger from transcription factor IIIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

A mass spectrometric comparison of the interactions of cisplatin and transplatin with myoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Spectropotentiometric analysis of metal binding to structural zinc-binding sites: accounting quantitatively for pH and metal ion buffering effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

A class of zinc fingers involved in protein-protein interactions biophysical characterization of CCHC fingers from fog and U-shaped.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Chemically crosslinked protein dimers: stability and denaturation effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Interactions of platinum(II) complexes with sulfur-containing peptides studied by electrospray ionization mass spectrometry and tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Metallothionein in carcinogenesis and cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Reversal of acquired cisplatin resistance by modulation of metallothionein in transplanted murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Estimation of globular protein secondary structure from circular dichroism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Estimation of binding parameters of enzyme-ligand complex from fluorometric data by a curve fitting procedure: seryl-tRNA synthetase-tRNA Ser complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Exploring Metallodrug–Protein Interactions by ESI Mass Spectrometry: The Reaction of Anticancer Platinum Drugs with Horse Heart Cytochrome c

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

Sequential Metal Binding by the RING Finger Domain of BRCA1†

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.200900308

[1H,15N] NMR studies of the aquation of cis-diamine platinum(II) complexes

21 January 2018

6

1 reference

https://api.crossref.org/works/10.1002/CBDV.200900308

Effect of cis-, trans-diamminedichloroplatinum(II) and DBP on human serum albumin

21 June 2024

9

1 reference

https://api.crossref.org/works/10.1002/CBDV.200900308

Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

21 June 2024

35

1 reference

https://api.crossref.org/works/10.1002/CBDV.200900308

21 June 2024

37

63

6221

Quinn J. E.

2003

1 reference

https://api.crossref.org/works/10.1002/CBDV.200900308

Reactions of cisplatin hydrolytes with methionine, cysteine, and plasma ultrafiltrate studied by a combination of HPLC and NMR techniques

21 June 2024

56

1 reference

https://api.crossref.org/works/10.1002/CBDV.200900308

Studies of interactions between platinum(II) complexes and some biologically relevant molecules

21 June 2024

63

1 reference

https://api.crossref.org/works/10.1002/CBDV.200900308

21 June 2024

Identifiers

1 reference

24 November 2017

1 reference